GlaxoSmithKline PLC (NYSE:GSK)
| 33.82 BATS BZX Real-Time Price As of 9:34am ET |  +0.21 / +0.62%Today’s Change | 31.43 Today|||52-Week Range 43.39 | -8.10% Year-to-Date |
Latest GSK News | Press Releases
Today’s Trading
| Previous close | 33.61 |
| Today’s open | 33.87 |
| Day’s range | 33.82 - 33.89 |
| Volume | 264,831 |
| Average volume (3 months) | 5,668,845 |
| Market cap | $84.5B |
Data as of 9:34am ET, 03/01/2021
Growth & Valuation
| Earnings growth (last year) | +23.68% |
| Earnings growth (this year) | -11.65% |
| Earnings growth (next 5 years) | +3.50% |
| Revenue growth (last year) | +1.55% |
| P/E ratio | 9.5 |
| Price/Sales | 2.12 |
| Price/Book | 4.20 |
Financials
| Next reporting date | April 28, 2021 |
| EPS forecast (this quarter) | $0.72 |
| Annual revenue (last year) | $43.7B |
| Annual profit (last year) | $7.4B |
| Net profit margin | 16.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
